(S1 (S (S (NP (DT The) (NN kinase) (NN GLK)) (VP (VBZ controls) (NP (NP (NN autoimmunity)) (CC and) (NP (NN NF-kappaB)) (NP (NN signaling))) (PP (IN by) (S (VP (VBG activating) (NP (NP (DT the) (NN kinase) (NN PKC-theta)) (PP (IN in) (NP (NN T) (NNS cells))))))))) (. .)))
(S1 (S (S (NP (NP (NN Protein) (NN kinase) (NN C-theta)) (PRN (-LRB- -LRB-) (NP (NN PKC-theta)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN transcription) (NN factor) (NN NF-kappaB))) (VP (VBN induced) (PP (IN by) (NP (NN signaling))) (PP (IN via) (NP (DT the) (NP (NP (NN T) (NN cell) (NN antigen) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (DT the) (JJ direct) (NN activator)) (PP (IN of) (NP (NN PKC-theta)))) (VP (VBZ is) (ADJP (JJ unknown)))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (DT the) (NN kinase) (NN GLK)) (PRN (-LRB- -LRB-) (NP (NN MAP4K3)) (-RRB- -RRB-))) (ADVP (RB directly)) (VP (VBD activated) (NP (NN PKC-theta)) (PP (IN during) (NP (NN TCR) (NN signaling)))))))) (. .)))
(S1 (S (S (NP (NN TCR) (NN signaling)) (VP (VBD activated) (NP (NN GLK)) (PP (IN by) (S (VP (VBG inducing) (NP (NP (PRP$ its) (JJ direct) (NN interaction)) (PP (IN with) (NP (DT the) (JJ upstream) (NN adaptor) (NN SLP-76))))))))) (. .)))
(S1 (S (S (NP (JJ GLK-deficient) (NNS mice)) (VP (VP (VBD had) (NP (JJ impaired) (JJ immune) (NNS responses))) (CC and) (VP (VBD were) (ADJP (JJ resistant) (PP (TO to) (NP (JJ experimental) (JJ autoimmune) (NNS encephalomyelitis))))))) (. .)))
(S1 (S (S (S (S (ADJP (JJ Consistent) (PP (IN with) (NP (DT that))))) (, ,) (NP (NP (NN people)) (PP (IN with) (NP (JJ systemic) (NN lupus) (NN erythematosus)))) (VP (VBD had) (NP (NP (JJ considerable) (VBN enhanced) (NN GLK) (NN expression)) (CC and) (NP (NP (NP (NN activation)) (PP (IN of) (NP (NN PKC-theta)))) (CC and) (NP (NP (DT the) (NN kinase) (NN IKK)) (PP (IN in) (NP (NN T) (NNS cells)))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (JJ GLK-overexpressing) (NN T) (NNS cells)))) (VP (VBD was) (VP (ADVP (RB directly)) (VBN correlated) (PP (IN with) (NP (NN disease) (NN severity))))))) (. .)))
(S1 (S (S (S (ADVP (RB Thus)) (, ,) (NP (NN GLK)) (VP (VBZ is) (NP (NP (DT a) (JJ direct) (NN activator)) (PP (IN of) (NP (NN PKC-theta)))))) (, ,) (CC and) (S (NP (NP (NN activation)) (PP (IN of) (NP (NN GLK-PKC-theta-IKK)))) (VP (MD could) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (JJ new) (JJ diagnostic) (NNS biomarkers)) (CC and) (NP (NP (JJ therapeutic) (NNS targets)) (PP (IN for) (NP (JJ systemic) (NN lupus) (NN erythematosus))))))))))) (. .)))
